Clinical results of IMAT in adenocarcinoma prostate cancer

被引：0
|
作者：
Gribaudo, S. [1 ]
Monetti, U. [1 ]
Mussano, A. [1 ]
La Sala, S. [1 ]
Di Gregorio, S. [1 ]
Richetto, V. [1 ]
Sardo, A. [1 ]
Trevisiol, E. [1 ]
Madon, E. [1 ]
Urgesi, A. [1 ]
机构：
[1] OIRM, S Anna Hosp, Turin, Italy
来源：
RADIOTHERAPY AND ONCOLOGY | 2006年 / 81卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1079
引用
收藏
页码：S440 / S440
页数：1
相关论文
共 50 条
  • [21] Prostate Cancer Masquerading as Colon Adenocarcinoma
    Patel, Preet
    Huang, Cheng
    Rosenvinge, Erik C. von
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (06) : XIX - XX
  • [22] Clinical implementation of intensity modulated arc therapy (IMAT) for rectal cancer.
    Duthoy, W
    De Gersem, W
    Boterberg, T
    Smeets, P
    Peeters, M
    De Neve, W
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 290S - 290S
  • [23] IMAT-SIM: A new method for the clinical dosimetry of intensity-modulated arc therapy (IMAT)
    Iori, Mauro
    Cagni, Elisabetta
    Nahum, Alan E.
    Borasi, Giovanni
    MEDICAL PHYSICS, 2007, 34 (07) : 2759 - 2773
  • [24] Neoadjuvant androgen suppression with radiation in the management of locally advanced adenocarcinoma of the prostate: Experimental and clinical results
    Zietman, AL
    Prince, EA
    Nakfoor, BM
    Shipley, WU
    UROLOGY, 1997, 49 (3A) : 74 - 83
  • [25] Prostate cancer pathologic parameters and clinical outcome: Results from the cooperative prostate cancer tissue resource (CPCTR)
    Melarned, J
    Datta, MW
    Becich, MJ
    Bosland, M
    Dhir, R
    Kajdacsy-Balla, A
    Orenstein, J
    Silver, S
    Berman, JJ
    LABORATORY INVESTIGATION, 2003, 83 (01) : 162A - 162A
  • [26] Prostate cancer pathologic parameters and clinical outcome: Results from the cooperative prostate cancer tissue resource (CPCTR)
    Melamed, J
    Datta, MW
    Becich, MJ
    Bosland, M
    Dhir, R
    Kajdacsy-Balla, A
    Orenstein, J
    Silver, S
    Berman, JJ
    MODERN PATHOLOGY, 2003, 16 (01) : 162A - 162A
  • [27] Oligometastatic Prostate Adenocarcinoma. Clinical-Pathologic Study of a Histologically Under-Recognized Prostate Cancer
    Manini, Claudia
    Gonzalez, Alba
    Buchser, David
    Garcia-Olaverri, Jorge
    Urresola, Arantza
    Ezquerro, Ana
    Fernandez, Iratxe
    Llarena, Roberto
    Zabalza, Inaki
    Pulido, Rafael
    Carracedo, Arkaitz
    Gomez-Iturriaga, Alfonso
    Lopez, Jose I.
    JOURNAL OF PERSONALIZED MEDICINE, 2020, 10 (04): : 1 - 9
  • [28] Clinical implementation of intensity-modulated arc therapy (IMAT) for rectal cancer
    Duthoy, W
    De Gersem, W
    Vergote, K
    Boterberg, T
    Derie, C
    Smeets, P
    De Wagter, C
    De Neve, W
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (03): : 794 - 806
  • [29] Clinical implementation of IMAT prostate treatment using Elekta synergy and ERGO++ treatment planning system
    Shiraishi, K.
    Nakagawa, K.
    Haga, A.
    Ohtomo, K.
    Okano, Y.
    Oritate, T.
    Yoda, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S650 - S650
  • [30] Clinical results of patients with prostate cancer treated with intensitiy modulated radiotherapy
    Boehmer, D
    Herschel, R
    Bohsung, J
    Eichwurzel, I
    Badakhshi, H
    Budach, V
    RADIOTHERAPY AND ONCOLOGY, 2004, 73 : S400 - S400
12345